Background. Despite the frequent occurrence of bacteremia due to gram-negative organisms in patients with underlying permanent pacemakers (PPMs) or implantable cardioverter defibrillators (ICDs), the outcome and treatment of these patients has received scant attention. In patients with PPMs or ICDs who have Staphylococcus aureus bacteremia, 45% have PPM/ICD infection.
The use of permanent pacemakers (PPMs) and implantable cardioverter-defibrillators (ICDs) has increased because of several factors, including an aging population and an increasing number of indications for the use of these devices. Worldwide, there are 13 million functioning PPMs and 1180,000 functioning ICDs [1] .
Infection is a devastating complication of PPM/ICD use. Rates of infection after system placement have varied considerably, from 0.13% to 19.9% [2, 3] , and an-timicrobial therapy alone (without removal of the entire system) is complicated by mortality and frequent infection relapse. Thus, the prevailing opinion is that the optimal management of PPM/ICD infection includes complete removal of the device and leads coupled with antimicrobial therapy [4] [5] [6] [7] [8] .
What should be done for patients with bacteremia but no other evidence of PPM/ICD infection? This question addresses a common clinical occurrence and immediately prompts 2 considerations. First, complete system removal should be undertaken if PPM/ICD infection is truly present. Second, unnecessary system removal should be avoided because of the potential lifesustaining nature of the device and because of the morbidity, mortality, and economic cost associated with device removal. Moreover, for bacteremia due to Staphylococcus aureus, published data indicate that underlying PPM/ICD infection is frequently present (even when there is no other clinical evidence of device involvement) and that complete system removal for patients with S. aureus bacteremia is warranted [6, 7] .
What should be done for patients with bacteremia due to microorganisms other than S. aureus? This is a critical question that has not been well studied. Gram-negative bacilli account for the causes of more cases of bacteremia in elderly patients than does S. aureus [9] . Therefore, we retrospectively evaluated 49 patients with a PPM or an ICD who had gramnegative bacteremia to determine the frequency of PPM/ICD infection.
METHODS
Medical records of patients who had a PPM or an ICD and who were hospitalized at Mayo Clinic (Rochester, MN) during the period of 1998-2005 were retrospectively reviewed. Individuals with gram-negative bacteremia were identified by computerized matches between databases from the Division of Cardiovascular Diseases and from the Department of Microbiology and from a manual review of medical records. All patients had a PPM or an ICD at the time of bacteremia; there were no patients with a cardiac resynchronization device. Specific organisms, clinical features, presumed origin of infection, management, and outcome of each episode of bacteremia were analyzed retrospectively.
Patients with only positive blood cultures from either a central intravenous catheter or an arterial catheter, in the absence of simultaneous positive blood cultures from a peripheral sample, were excluded. PPM/ICD infection was defined as previously described by Chamis et al. [7] : clinical evidence of PPM/ ICD infection includes local signs of inflammation at the generator site, including erythema, warmth, fluctuance, wound dehiscence, erosion, tenderness, or purulent drainage. PPM/ ICD-related endocarditis was clinically confirmed if valvular or lead vegetations were detected by echocardiography, or if the Duke criteria [10] for infective endocarditis were met. PPM/ ICD infection was microbiologically confirmed if cultures of tissue samples or swabs taken from the generator pocket and/ or lead(s) were positive for the same organism that was isolated in blood sample cultures. PPM/ICD infection was rejected if a patient had no evidence of PPM/ICD infection at the time of initial blood sample culture, did not undergo system removal, and did not develop relapsing infection during a 12-week follow-up period. The route of device infection was presumed to be via hematogenous seeding of the system if there was no evidence of generator pocket infection or if the device had not been manipulated in у1 year, as previously described [7] . Any cases that did not clearly meet the case definitions were retrospectively reviewed by an experienced investigator (L.M.B.).
Relapsing bacteremia was defined by the following events: (1) clinical resolution of the initial episode of bacteremia after completion of a treatment course, and (2) development of a subsequent episode of bacteremia caused by the same organism that was isolated from blood cultures during the initial episode of bacteremia. Definitions of nosocomial, health care-associated, and community-acquired bacteremia were as previously described [11] : nosocomial bacteremia was defined as a positive culture result from blood samples obtained from patients who had been hospitalized for у48 h; community-acquired bacteremia was defined as a positive culture result from blood samples obtained at the time of hospital admission or within 48 h after admission for patients not meeting the criteria for health careassociated bacteremia; and patients had health care-associated bacteremia if they received intravenous therapy at home in the previous 30 days, if they attended an outpatient infusion therapy center (such as a hemodialysis center) in the 30 days before bacteremia, if they were hospitalized in an acute care hospital for у2 days in the 90 days before bacteremia, or if they resided in a nursing home or long-term care facility.
Data were analyzed using JMP statistical software, version 5.1.2 (SAS Institute). We calculated 95% CIs using the exact binomial method. The Mayo Clinic Institutional Review Board reviewed and approved the study. The authors of this article had full access to the data and take responsibility for its integrity.
RESULTS
There were 49 patients who had a PPM or an ICD and who had gram-negative bacteremia, who met the study criteria, and who were included in the study. A single patient with 1 set of blood samples taken only from an arterial catheter that grew Citrobacter freundii was excluded. Patient demographic features are described in table 1. Thirty-seven patients (75%) had a PPM, and 12 (25%) had an ICD. Twenty-nine patients (59%) were male and 20 (41%) were female. Mean age ‫ע(‬ SD) at the time of bacteremia was years. Bacteremia oc-77.9 ‫ע‬ 10.3 curred a median of 1078 days after original PPM/ICD placement (range, 1-5272 days; interquartile range, 503-2368 days). In 7 patients (14%), bacteremia occurred !3 months after device placement. Sixteen patients (33%) underwent a devicerelated surgical procedure after the original system placement, including battery replacement, lead repositioning, or device upgrade; however, no patient had undergone such a procedure in the 3 months before bacteremia. Organisms isolated from blood cultures included Escherichia coli (22 c Definitions for nosocomial, health care-associated, and community-acquired bacteremia are described elsewhere [11] .
catheter in 3 cases (6%), skin/soft tissue in 2 cases (4%), and an unknown focus in 12 cases (25%). Two patients (4%), described below, were believed to have generator site infection as the source of bacteremia. Echocardiography was performed during the initial hospitalization for bacteremia in 13 patients (27%), and included transthoracic-only echocardiography in 6 patients (12%), transesophageal-only echocardiography in 5 patients (10%), and the use of both methods in 2 patients (4%). Twelve of the 13 patients who underwent echocardiography had no evidence of infective endocarditis, according to the modified Duke criteria [10] . One patient with P. aeruginosa bacteremia and definite ICD infection because of generator pocket infection had a lead thrombus that was noted on transthoracic echocardiogram; it was unclear whether this was a vegetation or a simple thrombus. None of the patients underwent diagnostic radionuclide scanning for the evaluation of PPM/ICD infection. Two (4%) of 49 patients (95% CI, 1.1%-13.7%) in the cohort met the standardized criteria for PPM/ICD infection (table 2). Both patients had an ICD and and had clinical evidence of pocket infection (including purulent drainage, erythema, warmth, and pocket dehiscence) upon presentation with bacteremia. One patient (mentioned above) developed P. aeruginosa bacteremia 546 days after a generator change (4075 days after original device placement). The patient experienced localized trauma to the generator pocket site ∼1 month before presentation. The results of sample cultures were positive from the generator pocket and lead tips at the time of device removal. He did not require device replacement. Antimicrobial therapy included intravenous ciprofloxacin for 14 days (2 days of which were prior to system extraction) and intravenous cefepime for 28 days after system extraction. The second patient had bacteremia with Salmonella species (non-Typhi) 152 days after generator change (1821 days after original device placement). Presenting symptoms for the second patient included pocket dehiscence, erythema, and fever. No known epidemiologic risk factors or exposure to Salmonella species were noted. She underwent device removal; Salmonella species also grew from cultures of samples taken from the generator pocket and from leads. She subsequently underwent ICD reimplantation in the contralateral chest wall 15 days after device extraction. Antimicrobial therapy in the second patient included intravenous ceftriaxone for 14 days (7 days of which were after the operation), as well as intravenous ertapenem for 21 days after the operation. A third patient sustained bacteremia from Serratia marcescens and was suspected of having PPM/ICD infection. However, because she had no local inflammatory changes at the generator pocket site, had normal echocardiography findings, and negative results of cultures of samples taken from the pocket site and leads at the time of device extraction, she was considered to have "possible" device infection.
Of the 49 patients with gram-negative bacteremia, 2 patients (4%) had definite PPM/ICD infection as defined by strict criteria. Both patients with definite PPM/ICD infection had a clear generator pocket infection at the time of bacteremia. None of the 3 patients who underwent device extraction had complications from the procedure. None of the 49 patients (95% CI, 0%-7.3%) in the cohort met the definition of hematogenous secondary PPM/ICD infection.
Details of antimicrobial therapy were available for 38 of 40 patients with gram-negative bacteremia who did not undergo system removal or did not die while admitted to the hospital. The median duration of antimicrobial therapy was 15 days (range, 11-31 days; interquartile range, 14-16 days). Specific antimicrobials included fluoroquinolones (administered to 72% of patients), cephalosporins (36%), penicillins (28%), and carbapenems (11%). Patients typically received intravenous antimicrobials followed by oral antimicrobials upon hospital discharge. No patient received long-term suppressive antimicrobial therapy. Among the 34 patients who survived 112 weeks and who did not undergo system removal, the median length of followup after bacteremia was 759 days (range, 98-2074 days; interquartile range, 331.5-1152.3 days). Two (5.8%) of these patients (95% CI, 1.6%-19.1%) developed relapsing bacteremia (caused by K. pneumoniae in both) at 74 and 107 days, respectively, after initial bacteremia. Both patients with relapsing bacteremia had alternative sources of relapse other than PPM/ICD infection; 1 had recurrent cholangitis from biliary obstruction due to malignancy, and the other had prostate cancer and a longterm indwelling urinary catheter. Neither of these patients had evidence of PPM/ICD infection at the time of bacteremia relapse, nor did they subsequently undergo system removal. Both survived their second episode of bacteremia.
Twelve patients (25%) died before 12 weeks of follow-up. Four of these patients underwent echocardiography while hospitalized (transthoracic for 2 and transesophageal for 2), and there was no evidence of lead or endocardial infection in each case. None of the patients who died underwent device extraction. Organisms causing bacteremia in the patients who died included P. aeruginosa (4 patients), E. coli (4 patients), Klebsiella species (2 patients), Stenotrophomonas species (1 patient), and Citrobacter species (1 patient).
PPM/ICD infection was, therefore, definitively rejected in 34 (69%) of the 49 patients because infection did not relapse after a follow-up period of 112 weeks (median duration of followup, 759 days). Of the remaining patients, only 2 (4%) had confirmed PPM/ICD infection, 1 had possible PPM/ICD infection, and 12 died before 12 weeks of follow-up.
DISCUSSION
Our investigation included 49 patients and represents, to our knowledge, the largest published cohort to date with gramnegative bacteremia and PPM/ICD. Only 2 (4%) of the 49 patients met strict criteria for definite PPM/ICD infection, and both had a generator pocket infection at the time of bacteremia. The route of infection in the patient with Pseudomonas bacteremia was presumably local chest wall trauma experienced 1 month prior to presentation. The route of infection in the patient with Salmonella bacteremia is unclear; the patient presented with pocket dehiscence and erythema and underwent a generator pack change 3 months before presentation. However, Salmonella species would be an unusual cause of contamination of the device at implantation, which suggests perhaps hematogenous seeding during bacteremia from another source. Of the 34 patients who were at risk for infection relapse and had follow-up of 112 weeks, only 2 (5%) developed relapsing bacteremia, and in both cases, it was due to alternate foci of infection. The median length of follow-up in these patients was 12 years.
Two previous investigations have provided convincing data that hematogenous dissemination with secondary seeding of a PPM/ICD occurs during S. aureus bacteremia [6, 7] . This observation has also been well documented in patients with other types of cardiovascular devices, including prosthetic cardiac valves [12, 13] . No previous studies, however, have examined the risk of PPM/ICD infection among patients with gramnegative bacteremia. According to our data-and in contrast to patients observed with S. aureus bacteremia-the risk of secondary seeding of a PPM/ICD because of gram-negative bacteremia from an ectopic source must be extremely low (0 of 49 cases; 95% CI, 0%-7.3%). Only 2 patients developed relapsing gram-negative bacteremia, and both had other foci of infection as a possible etiology. A less likely explanation is that secondary PPM/ICD infection occurs but that antimicrobial therapy is curative, even if the system is infected and is not removed.
Current guidelines for the management of infected cardiac devices include complete system removal followed by antimicrobial therapy [1, 8, 14] . Chamis et al. [7] recommend removal of the PPM/ICD system in patients with S. aureus bacteremia if there is clinical or echocardiographic evidence of lead vegetation, if no other source for S. aureus bacteremia is identified, or if there is relapse of bacteremia after a course of antimicrobial therapy. PPM/ICD infection accounts for significant cost (estimated to be $25,000-$35,000 per case) [15, 16] , and significant morbidity and mortality from lead extraction has been reported [17] [18] [19] . System extraction should, therefore, not be undertaken without sufficient evidence of PPM/ICD infection.
Our data do not support routine device removal in patients with a PPM or an ICD who develop gram-negative bacteremia unless there is evidence of generator pocket infection. Both of the patients with definite PPM/ICD infection in our study had clear, clinical evidence of concomitant generator pocket infection at the time of their bacteremia. None of the patients who had bacteremia associated with more common sources (such as the urinary tract) appeared to develop PPM/ICD infection. Clinicians often use the duration of bacteremia to help make decisions regarding system extraction. Because of the retrospective nature of our study and the small number of patients with serial blood sample culture results, we were unable to assess duration of bacteremia as a predictor of system infection. In patients with sustained gram-negative bacteremia without an obvious source and with normal findings from a physical examination of the generator site, evaluation for device infection (including echocardiogram) may be reasonable.
Prior studies of PPM/ICD infection have displayed marked differences in rates of PPM/ICD infection that depend on the timing of bacteremia after device placement, with early bacteremia (!1 year after device placement) being more likely to reflect current or subsequent system infection [7] . Endothelialization of implanted leads could be a key factor in the prevention of late infection and is usually complete within 1-3 months of implantation [14, 20] . It is not clear whether the marked, observed differences in rates of secondary PPM/ICD infection after bacteremia caused by S. aureus versus those caused by other gram-negative organisms are due to timing of bacteremia with these organisms, to intrinsic pathogen-related factors (such as biofilm formation or virulence factors), or to specific device-related factors, such as lead material and endothelialization of the leads. Prior examination of bacterial adherence to heart valves in vitro also showed differences in adherence of gram-positive versus gram-negative bacteria [21] Our study has several limitations, mainly resulting from its retrospective study design. Our institution is a tertiary referral center with inherent referral bias, although only 4 of the 49 patients initially presented to an outside facility before being transferred to our institution. Specific data on surgical antimicrobial prophylaxis were unavailable, although the standard practice at our institution has been to administer intravenous cefazolin prior to device implantation. Because of the low rate of PPM/ICD infection in our cohort, we were unable to analyze specific host or device factors that might impact a patient's proclivity to develop device infection. Our criteria for definite PPM/ICD infection included confirmation by echocardiography, but only 27% of patients underwent this procedure, and it was not possible to definitely exclude lead or valvular vegetations in all patients. However, the long duration of followup with a minimal number of cases of relapsing bacteremia allowed us to exclude PPM/ICD infection in most of these patients. Although an exact determination of the rate of PPM/ ICD infection in our patients with gram-negative bacteremia is desirable, it is not feasible because of the early mortality (!12 weeks) that commonly occurs with gram-negative bacteremia in the elderly population (observed in ∼25% of cases) [9, 22] . Moreover, the issue becomes clinically moot among the early mortality group, because concerns about relapsing bacteremia due to device infection are no longer present. Thus, for patients who survive 112 weeks, the risk of relapsing gram-negative bacteremia due to PPM/ICD infection is low.
The economic cost of S. aureus bacteremia in patients with cardiovascular devices is extremely high (estimated to be $40,000-$80,000 per case) [23] , a significant proportion of which is incurred by diagnostic and surgical procedures. Our investigation provides sentinel data that help to clarify the treatment of patients with a PPM or an ICD who present with gram-negative bacteremia. In contrast to published experience with bacteremia due to S. aureus, there were no cases in our cohort of apparent PPM/ICD infection due to pocket seeding. Management of these patients should not focus on the use of echocardiography to exclude either lead or endocardial vegetations, nor should empirical device extraction be undertaken unless local findings of generator site infection indicate otherwise.
